Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

South Africa Urged To Revoke Key COVID-19 Patents

Lilly's Baricitinib Patent Is Claimed To Be Limiting Access To Affordable Generics

Feb 16 2022

• By Chloe Kent

Eli Lilly world headquarters — MSF has its sights set on Lilly • Source: Alamy

Related Content

Coronavirus Notebook: South Africa To Build mRNA Vaccine Tech Transfer Hub, EMA OKs More Comirnaty Production Capacity

Jun 22 2021

See-Saw: Challenger Natco Is Now Licensee For Lilly’s Baricitinib

May 18 2021

Year Of IP: From The TRIPS Waiver Proposal To The Moderna-NIH Patent Tussle

Jan 14 2022

Pharma’s Voluntary Licensing In India Successful In 2021 – But There Were Some Delicate Moments

Jan 07 2022

Yes We Can: South African Scientists On Their Way With mRNA Vaccine

Feb 08 2022

Related Companies

Eli Lilly and Company

Additional Topics

South Africa Middle East and Africa Coronavirus COVID-19 Intellectual Property Regulation Vaccines BioPharmaceutical

More from Legal & IP

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window